Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Mitochondrial ferritin in neurodegenerative diseases

Yang H, Yang M, Guan H, Liu Z, Zhao S, Takeuchi S, Yanagisawa D, Tooyama I.

Neurosci Res. 2013 Sep-Oct;77(1-2):1-7. doi: 10.1016/j.neures.2013.07.005. Epub 2013 Jul 31.

Racial differences in restless legs symptoms and serum ferritin in an incident dialysis patient cohort

Kutner NG, Zhang R, Huang Y, Bliwise DL.

Int Urol Nephrol. 2012 Dec;44(6):1825-31. doi: 10.1007/s11255-011-0108-6. Epub 2012 Jan 5.

In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study

Oboshi Y, Ouchi Y, Yagi S, Kono S, Nakai N, Yoshikawa E, Futatsubashi M, Terada T, Kim K, Harada K.

J Cereb Blood Flow Metab. 2012 Apr;32(4):654-62. doi: 10.1038/jcbfm.2011.201. Epub 2012 Jan 11.

[Restless legs syndrome - a review]

Sveinsson OA, Sigurdsson AP.

Laeknabladid. 2012 Jan;98(1):33-7. doi: 10.17992/lbl.2012.01.410.

Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms

Weinstock LB, Walters AS, Paueksakon P.

Sleep Med Rev. 2012 Aug;16(4):341-54. doi: 10.1016/j.smrv.2011.09.003. Epub 2012 Jan 17.

Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis

Merlino G, Lorenzut S, Romano G, Sommaro M, Fontana A, Montanaro D, Valente M, Gigli GL.

Neurol Sci. 2012 Dec;33(6):1311-8. doi: 10.1007/s10072-012-0953-9. Epub 2012 Jan 22.

Efficacy and safety of dopamine agonists in restless legs syndrome

Hornyak M, Trenkwalder C, Kohnen R, Scholz H.

Sleep Med. 2012 Mar;13(3):228-36. doi: 10.1016/j.sleep.2011.09.013. Epub 2012 Jan 27.

Toward an animal model of restless legs syndrome?

Ghorayeb I, Bezard E.

Mov Disord. 2012 Mar;27(3):337-8. doi: 10.1002/mds.24905. Epub 2012 Jan 30.

Gabapentin enacarbil for treatment of restless legs syndrome in adults

Hayes WJ, Lemon MD, Farver DK.

Ann Pharmacother. 2012 Feb;46(2):229-39. doi: 10.1345/aph.1Q578. Epub 2012 Jan 31.

Cırcadian changes in cortical excitability in restless legs syndrome

Gündüz A, Adatepe NU, Kiziltan ME, Karadeniz D, Uysal O.

J Neurol Sci. 2012 May 15;316(1-2):122-5. doi: 10.1016/j.jns.2012.01.008. Epub 2012 Feb 2.

Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial

Sagheb MM, Dormanesh B, Fallahzadeh MK, Akbari H, Sohrabi Nazari S, Heydari ST, Behzadi S.

Sleep Med. 2012 May;13(5):542-5. doi: 10.1016/j.sleep.2011.11.010. Epub 2012 Feb 7.

Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults

Chen D, Lal R, Zomorodi K, Atluri H, Ho J, Luo W, Tovera J, Bonzo D, Cundy K.

Clin Ther. 2012 Feb;34(2):351-362.e3. doi: 10.1016/j.clinthera.2012.01.002.

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom disease): results from a prospective, multicenter study over 66 weeks

García-Borreguero D, Högl B, Ferini-Strambi L, Winkelman J, Hill-Zabala C, Asgharian A, Allen R.

Mov Disord. 2012 Feb;27(2):277-83. doi: 10.1002/mds.24889. Epub 2012 Jan 4.

Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep

Ferri R, Manconi M, Plazzi G, Bruni O, Cosentino FI, Ferini-Strambi L, Zucconi M.

Sleep Med. 2012 May;13(5):529-35. doi: 10.1016/j.sleep.2011.08.007. Epub 2012 Feb 15.

Migraine and restless legs syndrome in women

Schürks M, Winter AC, Berger K, Buring JE, Kurth T.

Cephalalgia. 2012 Apr;32(5):382-9. doi: 10.1177/0333102412439355. Epub 2012 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias